A detailed history of Artia Global Partners LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 442,504 shares of MRK stock, worth $45.3 Million. This represents 10.59% of its overall portfolio holdings.

Number of Shares
442,504
Previous 379,200 16.69%
Holding current value
$45.3 Million
Previous $50 Billion 9.49%
% of portfolio
10.59%
Previous 10.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $7.84 Million - $8.42 Million
63,304 Added 16.69%
442,504 $54.8 Billion
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $5.66 Million - $6.6 Million
50,000 Added 15.19%
379,200 $50 Billion
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $6.69 Million - $7.47 Million
65,000 Added 24.6%
329,200 $35 Billion
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $23.1 Million - $29.6 Million
264,200 New
264,200 $29.3 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $259B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.